Evidence map›Paper›PMID 33097276›Full record

ReviewTrends in genetics : TIG2021

All Creatures Great and Small: New Approaches for Understanding Down Syndrome Genetics.

Anna J Moyer, Katheleen Gardiner, Roger H Reeves

Open access · hybridAbstract readReview
In one paragraph

Review in Trends in genetics : TIG, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Vertebrate and Invertebrate Animal Models for the Study of Down Syndrome.International journal of molecular sciences · 2025
    Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Compensation of gene dosage on the mammalian X.Development (Cambridge, England) · 2024
    Review
  17. Article
  18. Folate gene polymorphismsInternational journal of reproductive biomedicine · 2024
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Anna J MoyerDepartment of Genetic Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD, USA; Department of Physiology, School of Medicine, Johns Hopkins University, Baltimore, MD, USA.
Katheleen GardinerDepartment of Pediatrics, University of Colorado School of Medicine, Aurora, CO, USA (retired).
Roger H ReevesDepartment of Genetic Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD, USA; Department of Physiology, School of Medicine, Johns Hopkins University, Baltimore, MD, USA. Electronic address: rreeves@jhmi.edu.
Johns Hopkins Medicine · USJohns Hopkins University · USUniversity of Colorado Denver · US

Funding

GENOMIC APPROACHES TO ANEUPLOIDYR01HD038384 · NICHD · JOHNS HOPKINS UNIVERSITY · PI REEVES, ROGER H · 2000 to 2020
$11.0M
Predoctoral Training Program in Human GeneticsT32GM007814 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI VALLE, DAVID · 1985 to 2021
$10.6M
Sleep and Circadian Dysfunction, Brain and Neurobehavioral Development in AutismP50HD103538 · NICHD · HUGO W. MOSER RES INST KENNEDY KRIEGER · PI S. Ali Fatemi, Bradley L Schlaggar · 2020 to 2026
$9.9M
Translational Neuroscience CoreU54HD079123 · NICHD · HUGO W. MOSER RES INST KENNEDY KRIEGER · PI FATEMI, S. ALI · 2014 to 2019
$7.9M
Chromosome 21 Elimination In A New Mouse Model of Down SyndromeR21HD098540 · NICHD · JOHNS HOPKINS UNIVERSITY · PI REEVES, ROGER H · 2019 to 2020
$450k
Cerebellar hypoplasia and chromosome elimination in mouse models of Down syndromeF31HD098826 · NICHD · JOHNS HOPKINS UNIVERSITY · PI MOYER, ANNA JOYCE · 2019 to 2021
$114k
NICHD NIH HHS F31 HD098826NICHD NIH HHS P50 HD103538NICHD NIH HHS R01 HD038384NICHD NIH HHS R21 HD098540NICHD NIH HHS U54 HD079123NIGMS NIH HHS T32 GM007814
6 · The paper itself

Abstract

Human chromosome 21 (Hsa21) contains more than 500 genes, making trisomy 21 one of the most complex genetic perturbations compatible with life. The ultimate goal of Down syndrome (DS) research is to design therapies that improve quality of life for individuals with DS by understanding which subsets of Hsa21 genes contribute to DS-associated phenotypes throughout the lifetime. However, the complexity of DS pathogenesis has made developing appropriate animal models an ongoing challenge. Here, we examine lessons learned from a variety of model systems, including yeast, nematode, fruit fly, and zebrafish, and discuss emerging methods for creating murine models that better reflect the genetic basis of trisomy 21.

Indexed as

AneuploidyAnimalsChromosomes, Human, Pair 21Disease Models, AnimalDown SyndromeDrosophilaGenomicsHumansMicePan troglodytesRatsYeastsZebrafishaneuploidycomplex diseasedisease modelsDown syndromemodel organismstrisomy 21

Identifiers

PMID33097276
PMCPMC8208824
OpenAlexW3094039995

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.